交易 Johnson & Johnson - JNJ CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
| 价差 | 0.30 | ||||||||
|
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
|
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
| 隔夜费时间 | 21:00 (UTC) | ||||||||
| 最小交易量 | 1 | ||||||||
| 货币 | USD | ||||||||
| 保证金 | 20% | ||||||||
| 上市交易所 | United States of America | ||||||||
| 交易费 | 0% |
*Information provided by Capital.com
Johnson & Johnson ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
|---|---|---|---|---|---|---|
| Mar 27, 2023 | 153.15 | 0.62 | 0.41% | 152.53 | 154.37 | 152.26 |
| Mar 24, 2023 | 152.36 | 1.50 | 0.99% | 150.86 | 152.61 | 150.26 |
| Mar 23, 2023 | 151.16 | -0.14 | -0.09% | 151.30 | 151.86 | 149.98 |
| Mar 22, 2023 | 151.07 | -2.31 | -1.51% | 153.38 | 154.35 | 150.86 |
| Mar 21, 2023 | 153.25 | -0.50 | -0.33% | 153.75 | 154.84 | 152.02 |
| Mar 20, 2023 | 153.48 | 2.23 | 1.47% | 151.25 | 153.91 | 151.25 |
| Mar 17, 2023 | 152.39 | -1.63 | -1.06% | 154.02 | 154.76 | 152.09 |
| Mar 16, 2023 | 153.71 | -0.67 | -0.43% | 154.38 | 154.56 | 152.46 |
| Mar 15, 2023 | 153.97 | 0.42 | 0.27% | 153.55 | 154.71 | 151.94 |
| Mar 14, 2023 | 153.11 | -1.36 | -0.88% | 154.47 | 155.15 | 151.73 |
| Mar 13, 2023 | 154.10 | 1.61 | 1.06% | 152.49 | 155.74 | 150.92 |
| Mar 10, 2023 | 151.38 | 0.37 | 0.25% | 151.01 | 153.33 | 150.36 |
| Mar 9, 2023 | 151.01 | -1.61 | -1.05% | 152.62 | 153.41 | 150.55 |
| Mar 8, 2023 | 152.36 | -1.59 | -1.03% | 153.95 | 154.64 | 152.32 |
| Mar 7, 2023 | 153.95 | -1.75 | -1.12% | 155.70 | 156.35 | 153.19 |
| Mar 6, 2023 | 155.55 | 1.59 | 1.03% | 153.96 | 155.56 | 153.96 |
| Mar 3, 2023 | 153.84 | 1.76 | 1.16% | 152.08 | 153.96 | 151.56 |
| Mar 2, 2023 | 152.07 | -0.09 | -0.06% | 152.16 | 152.61 | 151.07 |
| Mar 1, 2023 | 152.06 | -0.99 | -0.65% | 153.05 | 153.75 | 151.76 |
| Feb 28, 2023 | 153.15 | -2.26 | -1.45% | 155.41 | 155.79 | 152.85 |
Johnson & Johnson Events
| 時間（協調世界時） (UTC) | 國家 | 事件 |
|---|---|---|
| Monday, April 17, 2023 | ||
| 時間（協調世界時） (UTC) 12:30 | 國家 US
| 事件 Q1 2023 Johnson & Johnson Earnings Release Q1 2023 Johnson & Johnson Earnings ReleaseForecast -Previous - |
| Friday, April 28, 2023 | ||
| 時間（協調世界時） (UTC) 14:00 | 國家 US
| 事件 Johnson & Johnson Annual Shareholders Meeting Johnson & Johnson Annual Shareholders MeetingForecast -Previous - |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 总收入 | 94943 | 93775 | 82584 | 82059 | 81581 |
| 收入 | 94943 | 93775 | 82584 | 82059 | 81581 |
| 收入成本，共计 | 30989 | 29855 | 28327 | 27456 | 26986 |
| 毛利 | 63954 | 63920 | 54257 | 54603 | 54595 |
| 总营业费用 | 73218 | 70999 | 66087 | 64731 | 63582 |
| 销售/一般/行政费用，总计 | 24765 | 24659 | 22084 | 22178 | 22540 |
| 研究与开发 | 14603 | 14714 | 12159 | 11355 | 10775 |
| 利息费用（收入) - 净运营 | 814 | -370 | -410 | -183 | 394 |
| 异常费用（收入） | 5004 | 4041 | 4428 | 1456 | 1826 |
| Other Operating Expenses, Total | -2957 | -1900 | -501 | 2469 | 1061 |
| 营业收入 | 21725 | 22776 | 16497 | 17328 | 17999 |
| 税前净收入 | 21725 | 22776 | 16497 | 17328 | 17999 |
| 税后净收入 | 17941 | 20878 | 14414 | 15119 | 15297 |
| 未计算非常项目前的净收益 | 17941 | 20878 | 14414 | 15119 | 15297 |
| 净收入 | 17941 | 20878 | 14714 | 15119 | 15297 |
| 普通股股东可获收益 (不含非经常性项目) | 17941 | 20878 | 14414 | 15119 | 15297 |
| 普通股股东可获收益 (含非經常性項目) | 17941 | 20878 | 14714 | 15119 | 15297 |
| 摊薄净收入 | 17941 | 20878 | 14714 | 15119 | 15297 |
| 摊薄后加权平均股 | 2663.9 | 2674 | 2670.7 | 2684.3 | 2728.7 |
| 扣除特别项目的每股摊薄盈利 | 6.73486 | 7.80778 | 5.39709 | 5.63238 | 5.60597 |
| Dividends per Share - Common Stock Primary Issue | 4.45 | 4.19 | 3.98 | 3.75 | 3.54 |
| 每股正常摊薄盈利 | 8.67833 | 9.22111 | 6.98515 | 7.87 | 6.92185 |
| 非常规项目总计 | 300 |
| Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | |
|---|---|---|---|---|---|
| 总收入 | 23706 | 23791 | 24020 | 23426 | 24804 |
| 收入 | 23706 | 23791 | 24020 | 23426 | 24804 |
| 收入成本，共计 | 7711 | 7794 | 7902 | 7582 | 7955 |
| 毛利 | 15995 | 15997 | 16118 | 15844 | 16849 |
| 总营业费用 | 19505 | 17969 | 18180 | 17564 | 19968 |
| 销售/一般/行政费用，总计 | 6512 | 6089 | 6226 | 5938 | 7154 |
| 研究与开发 | 3841 | 3597 | 3703 | 3462 | 4720 |
| 利息费用（收入) - 净运营 | -77 | 101 | 74 | 388 | -153 |
| 异常费用（收入） | 1871.2 | 723 | 828 | 1382 | 1234 |
| Other Operating Expenses, Total | -353.2 | -335 | -553 | -1188 | -942 |
| 营业收入 | 4201 | 5822 | 5840 | 5862 | 4836 |
| 税前净收入 | 4201 | 5822 | 5840 | 5862 | 4836 |
| 税后净收入 | 3520 | 4458 | 4814 | 5149 | 4736 |
| 未计算非常项目前的净收益 | 3520 | 4458 | 4814 | 5149 | 4736 |
| 净收入 | 3520 | 4458 | 4814 | 5149 | 4736 |
| 普通股股东可获收益 (不含非经常性项目) | 3520 | 4458 | 4814 | 5149 | 4736 |
| 普通股股东可获收益 (含非經常性項目) | 3520 | 4458 | 4814 | 5149 | 4736 |
| 摊薄净收入 | 3520 | 4458 | 4814 | 5149 | 4736 |
| 摊薄后加权平均股 | 2653.1 | 2661.3 | 2667.9 | 2666.5 | 2672.2 |
| 扣除特别项目的每股摊薄盈利 | 1.32675 | 1.67512 | 1.80442 | 1.931 | 1.77232 |
| Dividends per Share - Common Stock Primary Issue | 1.13 | 1.13 | 1.13 | 1.06 | 1.06 |
| 每股正常摊薄盈利 | 2.02302 | 1.94069 | 2.12204 | 2.41406 | 2.22457 |
- 年度
- 每季度
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| 流动资产总额 | 60979 | 51237 | 45274 | 46033 | 43088 |
| 现金和短期投资 | 31608 | 25185 | 19287 | 19687 | 18296 |
| Cash | 2936 | 2863 | 2637 | 2619 | 2929 |
| 现金等价物 | 1901 | 2102 | 2864 | 3397 | 4288 |
| 短期投资 | 26771 | 20220 | 13786 | 13671 | 11079 |
| 应收账款总额，净额 | 15283 | 13576 | 14481 | 14098 | 13490 |
| Accounts Receivable - Trade, Net | 15283 | 13576 | 14481 | 14098 | 13490 |
| Total Inventory | 10387 | 9344 | 9020 | 8599 | 8765 |
| Prepaid Expenses | 3701 | 3132 | 2392 | 2699 | 2537 |
| Total Assets | 182018 | 174894 | 157728 | 152954 | 157303 |
| Property/Plant/Equipment, Total - Net | 19862 | 19766 | 18615 | 17035 | 17005 |
| Property/Plant/Equipment, Total - Gross | 48579 | 47804 | 44289 | 41851 | 41466 |
| Accumulated Depreciation, Total | -28717 | -28038 | -25674 | -24816 | -24461 |
| Goodwill, Net | 35246 | 36393 | 33639 | 30453 | 31906 |
| Intangibles, Net | 46392 | 53402 | 47643 | 47611 | 53228 |
| Other Long Term Assets, Total | 17655 | 12615 | 11409 | 11311 | 12076 |
| Total Current Liabilities | 45226 | 42493 | 35964 | 31230 | 30537 |
| Accounts Payable | 11055 | 9505 | 7537 | 7310 | |
| Accrued Expenses | 29293 | 28965 | 32496 | 20079 | 17467 |
| Notes Payable/Short Term Debt | 1635 | 832 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 2131 | 1799 | 1202 | 2297 | 3906 |
| Other Current Liabilities, Total | 1112 | 1392 | 2266 | 1317 | 1854 |
| Total Liabilities | 107995 | 111616 | 98257 | 93202 | 97143 |
| Total Long Term Debt | 29985 | 32635 | 26494 | 27684 | 30675 |
| Long Term Debt | 29985 | 32635 | 26494 | 27684 | 30675 |
| Deferred Income Tax | 7487 | 7214 | 5958 | 7506 | 8368 |
| Other Liabilities, Total | 25297 | 29274 | 29841 | 26782 | 27563 |
| Total Equity | 74023 | 63278 | 59471 | 59752 | 60160 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 3120 | 3120 | 3120 | 3120 | 3120 |
| Retained Earnings (Accumulated Deficit) | 123060 | 113890 | 110659 | 106216 | 101793 |
| Treasury Stock - Common | -39099 | -38490 | -38417 | -34362 | -31554 |
| Unrealized Gain (Loss) | -3 | 1 | 0 | 0 | 232 |
| Other Equity, Total | -13055 | -15243 | -15891 | -15222 | -13431 |
| Total Liabilities & Shareholders’ Equity | 182018 | 174894 | 157728 | 152954 | 157303 |
| Total Common Shares Outstanding | 2628.97 | 2632.51 | 2632.51 | 2662.32 | 2682.52 |
| Other Current Assets, Total | 0 | 94 | 950 | ||
| Long Term Investments | 1884 | 1481 | 1148 | 511 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| 流动资产总额 | 60424 | 60979 | 59889 | 53769 | 52533 |
| 现金和短期投资 | 30388 | 31608 | 31001 | 25306 | 24619 |
| Cash | 3128 | 2936 | 2607 | 2313 | 2247 |
| 现金等价物 | 1579 | 1901 | 2120 | 2618 | 2094 |
| 短期投资 | 25681 | 26771 | 26274 | 20375 | 20278 |
| 应收账款总额，净额 | 15594 | 15283 | 14911 | 14871 | 14938 |
| Accounts Receivable - Trade, Net | 15594 | 15283 | 14911 | 14871 | 14938 |
| Total Inventory | 10990 | 10387 | 10387 | 10100 | 9952 |
| Prepaid Expenses | 3452 | 3701 | 3590 | 3492 | 3024 |
| Total Assets | 178355 | 182018 | 179228 | 176440 | 172557 |
| Property/Plant/Equipment, Total - Net | 18701 | 19862 | 18478 | 18632 | 18367 |
| Property/Plant/Equipment, Total - Gross | 47702 | 47679 | 47347 | 47201 | 46430 |
| Accumulated Depreciation, Total | -29001 | -28717 | -28869 | -28569 | -28063 |
| Goodwill, Net | 34935 | 35246 | 35569 | 35819 | 35688 |
| Intangibles, Net | 44420 | 46392 | 47776 | 50244 | 51110 |
| Long Term Investments | 1452 | 1884 | 1867 | 1678 | 1452 |
| Other Long Term Assets, Total | 18423 | 17655 | 15649 | 16298 | 13407 |
| Total Current Liabilities | 43390 | 45226 | 44561 | 38721 | 40932 |
| Accounts Payable | 9309 | 11055 | 8961 | 8704 | 8503 |
| Accrued Expenses | 28076 | 29293 | 29641 | 25644 | 27202 |
| Notes Payable/Short Term Debt | 3800 | 1635 | 1300 | 600 | 300 |
| Current Port. of LT Debt/Capital Leases | 497 | 2131 | 2498 | 2573 | 3050 |
| Other Current Liabilities, Total | 1708 | 1112 | 2161 | 1200 | 1877 |
| Total Liabilities | 103646 | 107995 | 108956 | 106860 | 106723 |
| Total Long Term Debt | 28851 | 29985 | 30130 | 30310 | 30263 |
| Long Term Debt | 28851 | 29985 | 30130 | 30310 | 30263 |
| Deferred Income Tax | 6424 | 7487 | 7147 | 9016 | 6507 |
| Other Liabilities, Total | 24981 | 25297 | 27118 | 28813 | 29021 |
| Total Equity | 74709 | 74023 | 70272 | 69580 | 65834 |
| Common Stock | 3120 | 3120 | 3120 | 3120 | 3120 |
| Retained Earnings (Accumulated Deficit) | 124380 | 123060 | 121092 | 120154 | 116508 |
| Treasury Stock - Common | -39034 | -39099 | -38525 | -38594 | -38466 |
| Unrealized Gain (Loss) | -16 | -3 | 0 | 0 | 1 |
| Other Equity, Total | -13741 | -13055 | -15415 | -15100 | -15329 |
| Total Liabilities & Shareholders’ Equity | 178355 | 182018 | 179228 | 176440 | 172557 |
| Total Common Shares Outstanding | 2629.38 | 2628.97 | 2632.49 | 2631.99 | 2632.7 |
| Preferred Stock - Non Redeemable, Net | 0 |
- 年度
- 每季度
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| 净收入/起跑线 | 20878 | 14714 | 15119 | 15297 | 1300 |
| 经营活动产生的现金 | 23410 | 23536 | 23416 | 22201 | 21056 |
| 经营活动产生的现金 | 7390 | 7231 | 7009 | 6929 | 5642 |
| Deferred Taxes | -2079 | -1141 | -2476 | -1016 | 2406 |
| 非现金物品 | 1459 | 42 | -101 | 988 | 467 |
| Cash Taxes Paid | 4768 | 4619 | 4191 | 4570 | 3312 |
| 已付现金利息 | 990 | 904 | 995 | 1049 | 960 |
| 营运资金的变化 | -4238 | 2690 | 3865 | 3 | 11241 |
| 投资活动产生的现金 | -8683 | -20825 | -6194 | -3167 | -14868 |
| 资本支出 | -3652 | -3347 | -3498 | -3670 | -3279 |
| 其他投资现金流量项目，总计 | -5031 | -17478 | -2696 | 503 | -11589 |
| 融资活动产生的现金 | -14047 | -6120 | -18015 | -18510 | -7673 |
| 融资现金流项目 | 395 | -627 | 575 | -148 | -188 |
| Total Cash Dividends Paid | -11032 | -10481 | -9917 | -9494 | -8943 |
| 股票的发行（报废），净额 | -2420 | -2107 | -5792 | -4919 | -5296 |
| 债务的发行（退还），净额 | -990 | 7095 | -2881 | -3949 | 6754 |
| 外汇效应 | -178 | 89 | -9 | -241 | 337 |
| 现金净变化 | 502 | -3320 | -802 | 283 | -1148 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 5149 | 20878 | 16142 | 12475 | 6197 |
| Cash From Operating Activities | 3979 | 23410 | 17678 | 9388 | 4074 |
| Cash From Operating Activities | 1769 | 7390 | 5547 | 3733 | 1894 |
| Deferred Taxes | -926 | -2079 | -2564 | -685 | -730 |
| Non-Cash Items | 726 | 1459 | 1223 | 34 | -272 |
| Changes in Working Capital | -2739 | -4238 | -2670 | -6169 | -3015 |
| Cash From Investing Activities | -3634 | -8683 | -3323 | -604 | -185 |
| Capital Expenditures | -607 | -3652 | -2237 | -1490 | -677 |
| Other Investing Cash Flow Items, Total | -3027 | -5031 | -1086 | 886 | 492 |
| Cash From Financing Activities | -4385 | -14047 | -10611 | -8404 | -5125 |
| Financing Cash Flow Items | -373 | 395 | 269 | 213 | 188 |
| Total Cash Dividends Paid | -2787 | -11032 | -8241 | -5450 | -2659 |
| Issuance (Retirement) of Stock, Net | -1256 | -2420 | -1652 | -1526 | -1202 |
| Issuance (Retirement) of Debt, Net | 31 | -990 | -987 | -1641 | -1452 |
| Foreign Exchange Effects | 16 | -178 | -125 | -33 | -78 |
| Net Change in Cash | -4024 | 502 | 3619 | 347 | -1314 |
| 投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.8771 | 245753287 | 1454228 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.5542 | 142084378 | 198067 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.0211 | 125452825 | -986275 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5372 | 47958583 | 294671 | 2022-12-31 | LOW |
| State Farm Insurance Companies | Insurance Company | 1.0153 | 31675492 | 0 | 2022-12-31 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.861 | 26861119 | -1125820 | 2022-12-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8364 | 26093398 | 1700287 | 2022-12-31 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 0.8236 | 25695612 | 3814698 | 2022-12-31 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.7267 | 22671643 | 204861 | 2022-12-31 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7015 | 21884954 | 24625 | 2022-12-31 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 0.6562 | 20472848 | -1558866 | 2022-12-31 | LOW |
| BofA Global Research (US) | Research Firm | 0.6347 | 19800227 | -625991 | 2022-12-31 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.5901 | 18410390 | -654505 | 2022-12-31 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.5892 | 18382540 | 418336 | 2022-12-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 0.586 | 18280864 | 141119 | 2022-12-31 | LOW |
| Capital International Investors | Investment Advisor | 0.5632 | 17569654 | -1212751 | 2022-12-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.5477 | 17086571 | 174516 | 2022-12-31 | LOW |
| Wells Fargo Advisors | Research Firm | 0.5436 | 16958793 | 47687 | 2022-12-31 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.532 | 16596744 | -2192644 | 2022-12-31 | LOW |
| BlackRock Asset Management Ireland Limited | Investment Advisor | 0.4993 | 15576114 | -481392 | 2022-12-31 | LOW |
交易計算器
如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模（槓桿 x 投資）：
開倉
平倉
做空 做多
Johnson & Johnson Company profile
关于 Johnson & Johnson
强生公司是一家控股公司，从事医疗保健领域一系列产品的研究和开发、生产和销售。 公司通过三个部门运营。 消费者健康、制药和医疗设备。 其主要重点是与人类健康和福祉有关的产品。 消费者健康部门包括一系列产品，主要是用于皮肤健康/美容、非处方药、婴儿护理、口腔护理、妇女健康和伤口护理市场的个人保健。 制药部门专注于六个治疗领域。 免疫学、传染病、神经科学、肿瘤学、心血管和代谢以及肺动脉高压。 医疗设备部门包括一系列用于介入解决方案、骨科、外科和视觉领域的产品。 其地理区域包括美国、欧洲、西半球（不包括美国）以及非洲、亚洲和太平洋。
| Industry: | Pharmaceuticals (NEC) |
One Johnson & Johnson Plaza
08933
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗？
加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。